Open access
Open access
Powered by Google Translator Translator

Global & Public Health (All Articles)

COVID-19 Vaccine Janssen: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets

21 Apr, 2021 | 07:07h | UTC

COVID-19 Vaccine Janssen: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets – European Medicines Agency

Commentary: Johnson & Johnson vaccine: EU regulator says blood clot very rare side effect – BBC

 

Commentary on Twitter

 


What do we know about India’s Covaxin vaccine?

21 Apr, 2021 | 07:05h | UTC

What do we know about India’s Covaxin vaccine? – The BMJ

 


WHO panel comes out against requiring vaccination proof for travel

21 Apr, 2021 | 07:03h | UTC

WHO panel comes out against requiring vaccination proof for travel – The Hill

WHO Statement: Statement on the seventh meeting of the International Health Regulations (2005) Emergency Committee regarding the coronavirus disease (COVID-19) pandemic – World Health Organization

Related: Opinion | How to lose friends and alienate people? On the problems of vaccine passports (several texts on the subject)

 


We know a lot about Covid-19. Experts have many more questions

21 Apr, 2021 | 07:02h | UTC

We know a lot about Covid-19. Experts have many more questions – STAT

 


Large clinical trial to study repurposed drugs to treat COVID-19 symptoms

21 Apr, 2021 | 06:59h | UTC

Large clinical trial to study repurposed drugs to treat COVID-19 symptoms – NIH News Releases

 


Another study shows SARS-CoV-2 variant B.1.1.7 is more transmissible than the original virus

21 Apr, 2021 | 06:58h | UTC

BNT162b2 Vaccination Effectively Prevents the Rapid Rise of SARS-CoV-2 Variant B.1.1.7 in high risk populations in Israel – Cell Reports Medicine

Commentary: The British variant is 45% more contagious than the original virus – Tel Aviv University

Related: New studies suggest SARS-CoV-2 variant B.1.1.7 is not more deadly, just more transmissible AND Study confirms higher transmissibility of SARS-CoV-2 lineage B.1.1.7

 


Chlamydia and gonorrhea: new recommendation to screen sexually active patients under 30

20 Apr, 2021 | 05:42h | UTC

Guideline: Recommendation on screening for chlamydia and gonorrhea in primary care for individuals not known to be at high risk – Canadian Medical Association Journal

News release: Under 30 and sexually active? It’s a good idea to get tested for chlamydia and gonorrhea – Canadian Task Force on Preventive Health Care

Summary: Chlamydia and gonorrhea: new recommendation to screen sexually active patients under 30 – Canadian Task Force on Preventive Health Care

Related USPSTF Draft Statement: Screening for Chlamydia and Gonorrhea – U.S. Preventive Services Task Force

 


Perspective | The Confident Generalist: Putting The Primary Care Physician Back At The Center

20 Apr, 2021 | 05:35h | UTC

The Confident Generalist: Putting The Primary Care Physician Back At The Center – Health Affairs

 


M-A: Diagnostic performance of different sampling approaches for SARS-CoV-2 RT-PCR testing

20 Apr, 2021 | 06:09h | UTC

Diagnostic performance of different sampling approaches for SARS-CoV-2 RT-PCR testing: a systematic review and meta-analysis – The Lancet Infectious Diseases

Commentary: Beyond COVID-19—will self-sampling and testing become the norm? – The Lancet Infectious Diseases

Related Meta-analysis: Saliva and nasopharyngeal swab nucleic acid amplification have similar diagnostic accuracy for the detection of SARS-CoV-2 AND Saliva vs. nasopharyngeal swabs equally sensitive for Covid-19 diagnosis

 


[News release – not published yet] Sputnik V demonstrates 97.6% efficacy according to the analysis of data of 3.8 million vaccinated persons in Russia

20 Apr, 2021 | 06:08h | UTC

Sputnik V demonstrates 97.6% efficacy according to the analysis of data of 3.8 million vaccinated persons in Russia

 

Commentary on Twitter

 


COVID-19 dynamics after a national immunization program in Israel

20 Apr, 2021 | 06:06h | UTC

COVID-19 dynamics after a national immunization program in Israel – Nature Medicine

 

Commentary on Twitter

 


Pfizer CEO says third Covid vaccine dose likely needed within 12 months

20 Apr, 2021 | 06:02h | UTC

Pfizer CEO says third Covid vaccine dose likely needed within 12 months – CNBC

Commentary: Fully Vaccinated? Get Ready For Your Third Dose – Forbes

 


M-A: Prevalence of depression, anxiety and post-traumatic stress disorder in health care workers during the COVID-19 pandemic

20 Apr, 2021 | 06:00h | UTC

Prevalence of depression, anxiety and post-traumatic stress disorder in health care workers during the COVID-19 pandemic: A systematic review and meta-analysis – PLOS One

 


Ten scientific reasons in support of airborne transmission of SARS-CoV-2

18 Apr, 2021 | 21:51h | UTC

Ten scientific reasons in support of airborne transmission of SARS-CoV-2 – The Lancet

Commentary: Recognising that coronavirus is predominantly spread through air would save lives, argues new assessment – University of Oxford

Animated Videos: Aerosols and making spaces safe – University of Oxford

 

Commentary on Twitter (thread – click for more)

 


Indoor Air Changes and Potential Implications for SARS-CoV-2 Transmission

18 Apr, 2021 | 21:49h | UTC

Indoor Air Changes and Potential Implications for SARS-CoV-2 Transmission – JAMA

 

Commentary on Twitter (thread – click for more)

 


A guideline to limit indoor airborne transmission of COVID-19

18 Apr, 2021 | 21:47h | UTC

A guideline to limit indoor airborne transmission of COVID-19 – Proceedings of the National Academy of Sciences

 


China’s Sinovac COVID-19 vaccine 67% effective in preventing symptomatic infection, 85% effective in preventing hospitalizations and 80% effective in preventing deaths – Chile govt report

18 Apr, 2021 | 21:45h | UTC

China’s Sinovac COVID-19 vaccine 67% effective in preventing symptomatic infection – Chile govt report – Reuters

 

Commentary on Twitter (thread – click for more)

 


Editorial: SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia – “The very low prevalence of this complication of vaccination, however severe, relative to the benefits of preventing Covid-19 must be emphasized”

18 Apr, 2021 | 21:42h | UTC

SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia – New England Journal of Medicine

 


COVID vaccines and blood clots: five key questions

18 Apr, 2021 | 21:40h | UTC

COVID vaccines and blood clots: five key questions – Nature

See also (podcast): Coronapod: could COVID vaccines cause blood clots? Here’s what the science says – Nature

 


Study: Double masking improves protection from Covid-19 mostly by eliminating any gaps or poor-fitting areas of a mask

18 Apr, 2021 | 21:37h | UTC

Fitted Filtration Efficiency of Double Masking During the COVID-19 Pandemic – JAMA Internal Medicine

Commentaries: Fit matters most when double masking to protect yourself from COVID-19 – University of North Carolina Health Care AND Check your fit on that double mask if you want it to work against Covid, study says – CNN

 


Study shows past COVID-19 infection doesn’t fully protect young people against reinfection

18 Apr, 2021 | 21:35h | UTC

Study shows past COVID-19 infection doesn’t fully protect young people against reinfection – Mount Sinai School of Medicine

Original study: SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study – The Lancet Respiratory Medicine

Related Study: SARS-CoV-2 infection rates of antibody-positive vs. antibody-negative health-care workers – previous infection was associated with 84% lower risk of (re)infection

 

Commentary on Twitter

 


WHO: Benefits of continuing to provide life-saving HIV services outweigh the risk of COVID-19 transmission by 100 to 1

18 Apr, 2021 | 21:32h | UTC

Benefits of continuing to provide life-saving HIV services outweigh the risk of COVID-19 transmission by 100 to 1 – World Health Organization

 


WHO: Global shortage of innovative antibiotics fuels emergence and spread of drug-resistance

16 Apr, 2021 | 06:20h | UTC

News release: Global shortage of innovative antibiotics fuels emergence and spread of drug-resistance – World Health Organization

Report: 2020 antibacterial agents in clinical and preclinical development: an overview and analysis – World Health Organization

Commentary: WHO report highlights shortage of new antibiotics – CIDRAP

 


[Preprint] Risk of rare blood clotting much higher for COVID-19 than for vaccines

16 Apr, 2021 | 06:37h | UTC

News release: Risk of rare blood clotting higher for COVID-19 than for vaccines – University of Oxford

Original study (preprint): Cerebral venous thrombosis: a retrospective cohort study of 513,284 confirmed COVID-19 cases and a comparison with 489,871 people receiving a COVID-19 mRNA vaccine

Commentaries: Brain clots ‘more likely’ with Covid infection than vaccine – BBC AND Risk for Cerebral Venous Thrombosis Elevated After COVID-19 Diagnosis – NEJM Journal Watch AND Study: COVID much more likely than vaccines to cause blood clots – CIDRAP

 

Commentary on Twitter

 


CDC study suggests leaving middle seat empty could lower COVID-19 spread on planes by 23% to 57%

16 Apr, 2021 | 06:33h | UTC

Laboratory Modeling of SARS-CoV-2 Exposure Reduction Through Physically Distanced Seating in Aircraft Cabins Using Bacteriophage Aerosol — November 2020 – CDC Morbidity and Mortality Weekly Report

Commentaries: Keeping middle seats vacant on airplanes can reduce risk of Covid-19 exposure by up to 57%, CDC study says – CNN AND Leaving middle seat empty lowers COVID-19 spread on planes, modeling suggests – LiveScience

 


Stay Updated in Your Specialty

No spam, just news.